(Q39367312)

11 September 2017

title

GDF3 inhibits the growth of breast cancer cells and promotes the apoptosis induced by Taxol (English)

1 reference

11 September 2017

Qiang Li

1

1 reference

11 September 2017

Yichen Ling

series ordinal

2

1 reference

11 September 2017

Long Yu

series ordinal

3

1 reference

11 September 2017

publication date

10 April 2012

1 reference

Journal of Cancer Research and Clinical Oncology

11 September 2017

published in

1 reference

11 September 2017

volume

138

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

1073-1079

1 reference

Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Growth/differentiation factor 3 signals through ALK7 and regulates accumulation of adipose tissue and diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Significance of angiogenesis in tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

What is transforming growth factor-beta (TGF-beta)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Divergent effect of TGFbeta1 on growth and proteolytic modulation of human prostatic-cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Genomic profiling of tumor initiating prostatospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Role of transforming growth factor Beta in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Transforming growth factor beta triggers two independent-senescence programs in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

SNIP1: a new activator of HSE signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

The conditioned medium from a stable human GDF3-expressing CHO cell line, induces the differentiation of PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Two major Smad pathways in TGF-beta superfamily signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Deficiency of growth differentiation factor 3 protects against diet-induced obesity by selectively acting on white adipose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

GDF-3 is an adipogenic cytokine under high fat dietary condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Development of TGF-beta signalling inhibitors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1213-3

Mechanisms in TGF-β Action

21 January 2018

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Transforming growth factor-beta.

1 reference

PubMed

12 December 2020

Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma

1 reference

PubMed

12 December 2020

10.1007/S00432-012-1213-3

Identifiers

DOI

1 reference

11 September 2017

1 reference